Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glover, D. A.
Right arrow Articles by Zeltzer, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glover, D. A.
Right arrow Articles by Zeltzer, L. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 21, Issue 23 (December), 2003: 4395-4401
© 2003 American Society for Clinical Oncology

Impact of CNS Treatment on Mood in Adult Survivors of Childhood Leukemia: A Report From the Children’s Cancer Group

Dorie A. Glover, Julianne Byrne, James L. Mills, Leslie L. Robison, H. Stacy Nicholson, Anna Meadows, Lonnie K. Zeltzer

From the Department of Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute, University of California at Los Angeles; Department of Pediatrics and Jonsson Cancer Center, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA; Department of Hematology/Oncology, Children’s National Medical Center, Washington, DC; Epidemiology Branch, National Institutes of Child Health and Human Development, Department of Health and Human Services, Bethesda, MD; Department of Pediatrics, University of Minnesota, Minneapolis, MN; Department of Hematology/Oncology, Oregon Health Sciences University, Portland, OR; and Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA.

Address reprint requests to Dorie Glover, PhD, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute, University of California at Los Angeles Medical Center, 760 Westwood Plaza, 68-237 NPI, Los Angeles, CA 90024-175919; e-mail: nglover{at}ahs.llumc.edu.

Purpose: This study assessed the relationship between CNS treatment and psychologic mood using the Profile of Moods State (POMS), a standardized measure of affect, among a large sample of young adult survivors of childhood acute lymphoblastic leukemia (ALL; N = 555).

Patients and Methods: Survivors of childhood ALL (ages 18 to 33 years at study entry) participated in a structured telephone interview eliciting demographic, health, and behavioral data and the POMS. Treatment data included total dose of CNS irradiation (CRT) and intrathecal methotrexate (MTX) obtained from medical records.

Results: Mood disturbance was reported by 24% of survivors. High-dose CRT and MTX predicted disturbance rates modestly and primarily in combination with education variables. Interactions between educational achievement, a history of attendance in special education classes, and sex were better predictors than treatment type or dose. Nonwhite males, those younger than 12.5 years of age at diagnosis, and those with negative perceptions of current health and cancer’s impact on employment were also at greater risk for mood disturbance (P < .01 to .001).

Conclusion: Although most survivors are doing well psychologically, a subset of long-term survivors show potentially serious mood disturbance. Mood disturbance seems to be a function of interactions between preexisting individual difference variables (eg, sex, race/ethnicity), treatment factors, and posttreatment educational experiences. Prevention strategies aimed at childhood cancer survivors at greatest risk for mood disturbance may be improved by focus on posttreatment psychosocial and educational supports.

Supported by grants from the Division of Cancer Treatment, National Cancer Institute, and the National Institute of Child Health and Development, National Institutes of Health, Department of Health and Human Services, Bethesda, MD. Contributing Children’s Cancer Group investigators, institutions, and grant numbers are given in the Appendix.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Pediatr PsycholHome page
L. K. Campbell, M. Scaduto, D. Van Slyke, F. Niarhos, J. A. Whitlock, and B. E. Compas
Executive Function, Coping, and Behavior in Survivors of Childhood Acute Lymphocytic Leukemia
J. Pediatr. Psychol., April 1, 2009; 34(3): 317 - 327.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pediatric Oncology NursingHome page
K. M. Boydell, E. Stasiulis, M. Greenberg, C. Greenberg, and B. Spiegler
I'll Show Them: The Social Construction of (In)Competence in Survivors of Childhood Brain Tumors
Journal of Pediatric Oncology Nursing, June 1, 2008; 25(3): 164 - 174.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. K. Zeltzer, Q. Lu, W. Leisenring, J. C.I. Tsao, C. Recklitis, G. Armstrong, A. C. Mertens, L. L. Robison, and K. K. Ness
Psychosocial Outcomes and Health-Related Quality of Life in Adult Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study
Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 435 - 446.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. Burkhardt, W. Woessmann, M. Zimmermann, U. Kontny, J. Vormoor, W. Doerffel, G. Mann, G. Henze, F. Niggli, W.-D. Ludwig, et al.
Impact of Cranial Radiotherapy on Central Nervous System Prophylaxis in Children and Adolescents With Central Nervous System-Negative Stage III or IV Lymphoblastic Lymphoma
J. Clin. Oncol., January 20, 2006; 24(3): 491 - 499.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online